共 5 条
[1]
Doxifluridine combined with weekly paclitaxel for second-line treatment in patients with gastric cancer resistant to TS-1[J] Wataru Arai;Yoshinori Hosoya;Masanobu Hyodo;Hidenori Haruta;Kentaro Kurashina;Shin Saito;Yuuki Hirashima;Taku Yokoyama;Toru Zuiki;Kazuya Sakuma;Yoshikazu Yasuda;Hideo Nagai International Journal of Clinical Oncology 2007,
[2]
A phase I/II study of S-1 plus cisplatin in patients with advanced gastric cancer: 2-week S-1 administration regimen[J] Yasuhiro Sato;Hitoshi Kondo;Kana Honda;Daisuke Takahari;Tetsuya Sumiyoshi;Yasushi Tsuji;Naohito Yoshizaki;Yoshiro Niitsu International Journal of Clinical Oncology 2005,
[3]
Combination chemotherapy of S-1 and low-dose cisplatin for advanced gastric cancer[J] Shunichi Tsujitani;Kenji Fukuda;Nobuaki Kaibara Gastric Cancer 2003,
[4]
Development of a novel form of an oral 5-fluorouracil derivative (S-1) directed to the potentiation of the tumor selective cytotoxicity of 5-fluorouracil by two biochemical modulators[J] Tetsuhiko Shirasaka;Yuji Shimamato;Hideyuki Ohshimo;Masahiro Yamaguchi;Toshiyuki Kato;Kazuhiko Yonekura;Masakazu Fukushima Anti-Cancer Drugs 1996,
[5]
An advancedpulmonary adenocarcinoma case in which TS-1 proved ef-fective Hayashi H;Mastushima Y;Kato H;et al; Gan To Kagaku Ryoho 2006,

